S357-0316 Screening compound: 1-[6-(4-methoxyphenyl)-5H,6H,8H-imidazo[4,3-c][1,4]oxazine-1-carbonyl]-N-(2-phenylethyl)piperidine-4-carboxamide

S357-0316 Screening compound: 1-[6-(4-methoxyphenyl)-5H,6H,8H-imidazo[4,3-c][1,4]oxazine-1-carbonyl]-N-(2-phenylethyl)piperidine-4-carboxamide
S357-0316 Screening compound: 1-[6-(4-methoxyphenyl)-5H,6H,8H-imidazo[4,3-c][1,4]oxazine-1-carbonyl]-N-(2-phenylethyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S357-0316
1-[6-(4-methoxyphenyl)-5H,6H,8H-imidazo[4,3-c][1,4]oxazine-1-carbonyl]-N-(2-phenylethyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S357-0316

Molecular Formula

C28H32N4O4 (C28 H32 N4 O4)

Compound Name

1-[6-(4-methoxyphenyl)-5H,6H,8H-imidazo[4,3-c][1,4]oxazine-1-carbonyl]-N-(2-phenylethyl)piperidine-4-carboxamide

IUPAC name

1-[6-(4-methoxyphenyl)-5H6H8H-imidazo[43-c][14]oxazine-1-carbonyl]-N-(2-phenylethyl)piperidine-4-carboxamide

SMILES

COc1ccc(C2OCc3c(C(N(CC4)CCC4C(NCCc4ccccc4)=O)=O)ncn3C2)cc1

InChI

InChI=1S/C28H32N4O4/c1-35-23-9-7-21(8-10-23)25-17-32-19-30-26(24(32)18-36-25)28(34)31-15-12-22(13-16-31)27(33)29-14-11-20-5-3-2-4-6-20/h2-10,19,22,25H,11-18H2,1H3,(H,29,33)/t25-/m1/s1

InChI Key

KNNQGGHXUVBKLK-RUZDIDTESA-N

MDL Number (MFCD)

MFCD29000760

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

488.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.902

Distribution Coefficient, logD

1.902

Water Solubility, LogSw

-2.20

Polar Surface Area

68.369

Acid Dissociation Constant (pKa)

13.94

Base Dissociation Constant (pKb)

0.27

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.29

S357-0316 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Bromodomain Modulators Library (5801 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with S357-0316 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S357-0316?
Check Price and Availability of S357-0316, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S357-0316 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S357-0316
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S357-0316
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S357-0316 available by request